Muh Geot Wong University of SydneyAustralia

Dr Wong is an Associate Professor in Medicine, University of Sydney and Senior Consultant Nephrologist at the Concord Repatriate General Hospital, Sydney, Australia. He is a Clinician researcher with a strong interest in understanding the pathomechanism of kidney fibrosis and has actively promoted the development of both clinical and pre-clinical research in delaying chronic kidney disease progression in IgA nephropathy, diabetic nephropathy, and management of cardiovascular complications associated with CKD. He has served as co-Chair of the Clinical Trials and Translation Research Enabler Committee of the Kolling Institute and the Co-Chair of the Research Group for the Chronic and Complex Medicine Network for Northern Sydney Lower Health District. He was the program Chair of the Nephrology and Transplantation Update Course for the Scientific Program and Education Committee, ANZSN, the Chair of the Education Committee for the Asia Pacific Society of Nephrology. He currently serves as Chair of the Oceania South East Asia Regional Board, International Society of Nephrology.

1 APRIL 2023

Time Session
14:15
15:15
Liz Lightstone Chairperson Imperial College London and Hammersmith HospitalUnited Kingdom
Sydney Tang Chairperson The University of Hong KongHong Kong, China
  • STOP-ACEi Study
    Sunil Bhandari Speaker Hull & East Yorkshire Hospitals NHS Trust United Kingdom
  • Q and A
  • DETERMINANTS OF THE EFFECTS OF SGLT2i ON PROGRESSION OF CKD: FURTHER RESULTS FROM THE EMPA-KIDNEY TRIAL
    Natalie Staplin Free Communication University of OxfordUnited Kingdom
  • Q and A
  • SPARSENTAN REDUCES PROTEINURIA IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IGAN): INTERIM RESULTS OF THE PROTECT STUDY
    Muh Geot Wong Speaker University of SydneyAustralia
  • Q and A
  • RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL OF ARTESUNATE IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS
    Jianwen YU Free Communication The First Affiliated Hospital of Sun Yat-sen UniversityChina
  • Q and A
Plenary Halls 2 & 3
17:00
18:00
  • Acid-base and Electrolyte Abnormalities in Kidney Disease
    Andréa Stinghen Moderator Universidade Federal do ParanáBrazil
  • Acute Kidney Injury Clinical, Drugs, AKI-CKD Continuum 2
    Rolando Claure-Del Granado Moderator Hospital Obrero No 2 - C.N.S.Bolivia
  • Chronic Kidney Disease Complications (CVD, Hypertension, Anemia, BMD, Nutrition, Infection) 3
    Kraiwiporn KIATTISUNTHORN Moderator Siriraj HospitalThailand
  • Chronic Kidney Disease Diagnosis, Classification and Progression 2
    Richard Kitching Moderator Monash University, Monash Medical CenterAustralia
  • Chronic Kidney Disease, Experimental Models, Biomarkers, Precision Medicine 2
    Wenjun Ju Moderator wenjunj@med.umich.eduUniversity Of Michigan Medical CenterUnited States
  • Clinical Glomerulonephritis 3
    Hernan Trimarchi Moderator HOSPITAL BRITANICO DE BUENOS AIRESArgentina
  • Covid-19 and CKD
    Opeyemi Olabisi Moderator Duke UniversityUnited States
  • Curriculum
    Prapaipim Thirakhupt Moderator prapaipimt@yahoo.com
  • Diabetic Kidney Disease, Drugs and Treatments 2
    Dr Giorgina Barbara Piccoli Moderator gpiccoli@ch-lemans.frCHM Le MansFrance
  • Epidemiology, Outcomes and Health Service Research Related to CKD or Its Complications 2
    Sabine Karam Moderator Saint George Hospital University Medical CenterLebanon
  • Epidemiology, Outcomes and Health Services Research in Dialysis 2
    Ana Elizabeth Figueiredo Moderator anaef@pucrs.brBrazil
  • Essential Hypertension and Renovascular Kidney Disease
    Barry Freedman Moderator Wake Forest University School of Medicine United States
  • Genetics and Epigenetics (Including Common and Rare Genetic Diseases)
    Chairat Shayakul Moderator Faculty of Medicine Siriraj Hospital, THAILANDThailand
  • Haemodialysis, Haemodiafiltration and Vascular Access 2
    Brendan Smyth Moderator St George HospitalAustralia
  • Haemodialysis, Haemodiafiltration and Vascular Access 3
    Jonathan Himmelfarb Moderator jhimmelfarb@nephrology.washington.eduKidney Research Institute, University of Washington United States
  • Inflammation, Fibrosis, Matrix Biology and Oxidative Stress
    Youhua LIU Moderator University of PittsburghUnited States
  • Kidney Transplantation and Transplant Immunology 3
    Narayan Prasad Moderator Sanjay Gandhi Post Graduate Institute of Medical SIndia
  • Kidney Transplantation and Transplant Immunology 4
    Professor Yingyos Avihingsanon Moderator yingyos@hotmail.com
  • Late Breaking Clinical Trials
    Muh Geot Wong Moderator University of SydneyAustralia
  • Nephrotic Syndrome
    Alessia Fornoni Moderator University of MiamiUnited States
  • Other CKD 2
    Jie Dong Moderator jie.dong@bjmu.edu.cnPeking University First HospitalChina
  • Other KF (Kidney Failure)
    Tai Shuan Lai Moderator National Taiwan University HospitalTaiwan
  • Peritoneal Dialysis 2
    Piyatida Chuengsaman Moderator Thailand
  • Peritoneal Dialysis 3
    Afiatin Abdurahman Moderator
  • Training
    Naowanit Nata Moderator
  • Tropical Kidney Diseases (Viral Nephropathies, TB, Schistosomiasis, Malaria, Leptospirosis, Animal Venoms)
    Opas Traitanon Moderator
  • Urologic Disorders – Stones, Nephrocalcinosis
    Sritippayawan Suchai Moderator Siriraj Hospital Thailand
  • Vascular Biology and Endothelial Function
    Reiko Inagi Moderator Univ of Tokyo - Grad. School of MedicineJapan
Ballroom 2-3-4-Exhibition Hall

2 APRIL 2023

Time Session
08:30
10:00
Alessia Fornoni Chairperson University of MiamiUnited States
Muh Geot Wong Chairperson University of SydneyAustralia
  • CKD with Diabetes vs. Diabetic Nephropathy
    Hans-Joachim Anders Speaker hjanders@med.uni-muenchen.deLMU MUnichGermany
  • Treatment 1 (SGLT2, GLP1)
    Julia Weinmann Menke Speaker Medical Center of Johannes Gutenberg University MainzGermany
  • Treatment 2 (Finrenone, etc.)
    Vuddhidej Ophascharoensuk Speaker Chiang Mai UniversityThailand
  • Prevention of DKD
    Juliana Chan Speaker The Chinese University of Hong KongHong Kong, China
  • Q and A
Plenary Hall 1

INDUSTRY SYMPOSIA PROGRAM (FRIDAY, MARCH 31, 2023)

Time Session
13:00
14:00
Organized by Travere Therapeutics
Muh Geot Wong Chairperson University of SydneyAustralia
  • IgA nephropathy: A Deep Dive into The Treatment Landscape
    Muh Geot Wong Speaker University of SydneyAustralia
  • Panel discussion: Evolving Landscape in IgA Nephropathy Patient Management
    Muh Geot Wong Speaker University of SydneyAustralia
    Sian Griffin Speaker
    Vivekanand Jha Speaker vjha@georgeinstitute.org.inThe George Institute for Global HealthIndia
MR 109 ABFE